Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
V-type proton ATPase catalytic subunit A (ATP6V1A) is a ubiquitous enzyme subunit that forms part of the V1 domain of the vacuolar-type H+-ATPase (V-ATPase) complex. V-ATPases are responsible for the ATP-dependent acidification of intracellular organelles, which is crucial for a variety of processes including protein sorting, receptor-mediated endocytosis, synaptic vesicle loading, and lysosomal degradation. The A subunit is the catalytic core, directly involved in ATP hydrolysis, providing the energy for proton transport by the V0 domain across organelle membranes. Mutations in ATP6V1A can lead to disorders such as developmental and epileptic encephalopathy and connective tissue diseases. Pharmacological inhibition of V-ATPase, such as by bafilomycin or concanamycin, is a useful research tool but highly toxic due to the central role of ATP6V1A-containing complexes in cellular physiology[1][2][5].
Inhibition of proton transport by blocking ATP hydrolysis (V-ATPase inhibitors prevent acidification of intracellular compartments)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on V-type proton ATPase catalytic subunit A (ATP6V1A).